A case of refractory IgG4-related disease successfully treated with daratumumab and lenalidomide
Rheumatology (Oxford)
.
2024 Aug 24:keae448.
doi: 10.1093/rheumatology/keae448.
Online ahead of print.
Authors
Denis Coulomb
1
,
Vanessa Szablewski
2
,
Nicolas Robert
3
,
Anne-Marie Dupuy
4
,
Rayane Berrahouane
1
,
Radjiv Goulabchand
5
,
Jérôme Moreaux
3
6
7
,
Alexandre Thibault Jacques Maria
8
9
,
Charles Herbaux
1
6
Affiliations
1
Department of Clinical Hematology, CHU de Montpellier, Montpellier, France.
2
Department of Pathology, CHU de Montpellier, Montpellier, France.
3
Department of Biological Hematology, CHU de Montpellier, Montpellier, France.
4
Department of Biochemistry, CHU de Montpellier, Montpellier, France.
5
Desbrest Institute of Epidemiology and Public Health, University of Montpellier and INSERM, Montpellier, France.
6
UMR CNRS-UM 9002, Institute of Human Genetics, Montpellier, France.
7
Institut Universitaire de France (IUF), Paris, France.
8
Department of Internal Medicine & Onco-Immunology (MedI2O), CHU de Montpellier, Montpellier, France.
9
Institute for Regenerative Medicine and Biotherapy (IRMB), University of Montpellier, Montpellier, France.
PMID:
39180414
DOI:
10.1093/rheumatology/keae448
No abstract available